Premenstrual Syndrome Clinical Trials

A listing of Premenstrual Syndrome medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
Featured trial
Does Severe PMS Rule Your Life?

Does Severe PMS Rule Your Life?

  • 448 views
  • 08 Nov, 2020
  • 2 locations
Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma

Glioblastoma is a highly aggressive and fatal form of primary malignant brain tumor with limited treatment options. fb-PMT affects a large group of cancer cell signaling pathways and thus may be

recurrent glioblastoma
karnofsky performance status
cancer
brain tumor
  • 0 views
  • 04 Oct, 2022
  • 1 location
An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001) (PMS-001)

A study of the safety, tolerability and pharmacokinetics of NNZ-2591 and measures of efficacy in children and adolescents with Phelan-McDermid Syndrome.

  • 0 views
  • 07 Oct, 2022
  • 1 location
Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Korea

The Korea HM3 PMS is a prospective, single arm, post market surveillance is designed to evaluate clinical and functional outcomes with the HM3 LVAS as a treatment for advanced heart failure. The

  • 0 views
  • 25 May, 2022
  • 12 locations
Impact of Preoperative Myocardial Fibrosis Related to Mitral Valve Prolapse on Postoperative Left Ventricular Remodeling (IMPARED)

(PMs). This fibrosis is developed beyond the volume overload related to the MVP. It is probably linked to the mechanical stretch acting upon the valve and the neighboring left ventricle (LV

mitral valve repair
prolapse
MRI
left ventricular remodeling
  • 0 views
  • 04 Oct, 2022
  • 1 location
An Open-Label, Single-Arm 4-Year Study to Evaluate Effectiveness and Safety of Ocrelizumab Treatment in Patients With Progressive Multiple Sclerosis (CONSONANCE)

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).

  • 359 views
  • 18 Oct, 2022
  • 2 locations
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis (CALLIPER)

Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with Progressive Multiple Sclerosis - CALLIPER

disease or disorder
MRI
  • 0 views
  • 04 Oct, 2022
  • 47 locations
China Post-marketing Surveillance (PMS) Study of Aldurazyme®

This is a single treatment arm study that is open-label to be conducted in Chinese participants with MPS I. Trial Objectives are to evaluate the safety and tolerability of Aldurazyme in Chinese MPS I participants, and to evaluate the efficacy of Aldurazyme on the percent change of urinary glycosaminoglycans (uGAGs) …

  • 0 views
  • 12 May, 2022
  • 1 location
China Post-marketing Surveillance (PMS) Study of Aldurazyme®

This is a single treatment arm study that is open-label to be conducted in Chinese participants with MPS I. Trial Objectives are to evaluate the safety and tolerability of Aldurazyme in Chinese MPS I participants, and to evaluate the efficacy of Aldurazyme on the percent change of urinary glycosaminoglycans (uGAGs) …

  • 34 views
  • 20 Jan, 2023
  • 1 location
A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism

This clinical trial will use growth hormone as a novel treatment for Phelan-McDermid syndrome (PMS) and idiopathic autism. A double-blind, placebo-controlled crossover trial design will be used

  • 0 views
  • 04 Oct, 2022